Stock Information
Organon & Co (OGN)
Ticker Symbol: OGN
Exchange: NYSE
Sector: Pharmaceuticals
Market Cap: $3,488.23 mil
Piotroski score: 7
PE Ratio: 14.3368
EPS (TTM): 0.9387
Revenue (TTM): $23.44 M
Dividend Yield: 0.59568131049888%
ROE: 29.87%
Latest News
-
Organon And Samsung Bioepis Expand Their Development And Commercialization Agreement To Provide OGN With Commercialization Rights In Canada To PYZCHIVA, Samsung Bioepis's Biosimilar Referencing STELARA
Thu, Jun 18, 2026 6:08 AM
-
Organon & Co. (OGN) Shareholder/Analyst Call - Slideshow
Wed, Jun 17, 2026 7:01 PM
Key Financials
Financial data not available
